You will be redirected to:

Continue
Logo - Kls
Logo - Kls
  • Playbook
  • Services
    Services
    Delivery models
  • Insights
  • Technology
  • Careers
  • About us
    Company purpose
    Life science innovation
    Committed Keyrus
    Regulatory compliance
    Investors
    Management team
    Keyrus Group
    Locations

Facilitate the provision of an innovative treatment thanks to a Managed Access Program (MAP)

<2

months to implement the program

<48

Hours before health professionnals response

Background

A world leader in the pharmaceutical industry has entrusted Keyrus Life Science with the implementation and complete management of a "Managed Access Program". The program objective is to promote treatments that demonstrated their efficiency in clinical trials and are not yet available on the market towards patients who would need them.

Challenge

This early access for an innovative and promising treatment was very highly expected by healthcare professionals and patients (>1000 patients expected over 2 years). Nevertheless, the project required a relatively cumbersome process for treatment requests (2 different systems, with several validations) which may be likely to mar the commitment of healthcare professionals. A fluid and important communication with the Key Opinion Leaders was therefore a crucial aspect to ensure the success of the project.

Approach

To manage this program and meet the expectations of the client, healthcare professionals and patients, we dedicated a multidisciplinary team: CRA (Clinical Research Associate), Project Manager, Data Management, Pharmacovigilance expert, etc. This team, in charge of the end-to-end management of the requests, had to be very agile and reactive in order to ensure a quick processing of the requests, despite the complexity of the process.

Key results

01
More than 100 patients benefited from early access to treatment in the first 2 months of the program
02
Client satisfaction with the implementation and management of the program
03
Prescriber satisfaction: short response times and efficient management of logistics

Benefits

The process put in place for the management of the program enabled us to efficiently manage all requests for compassionate access for this treatment. Despite the complexity of this process and the large number of requests, all were processed within the expected timeframe, ensuring the satisfaction of all stakeholders: client, healthcare professionals and patients.

Technology partners

Ennov Clinical

Share this key play

whatsapptwitter
linkedinfacebookworkplace

Ready for your own success story?

Get in touch with our team of experts.



I acknowledge having read the privacy policy.

Keyrus collects and processes the data you fill out in this form in order to respond to your request and for commercial prospecting purposes. The fields marked with an asterisk must be filled in for your request to be processed. To learn more about how we manage your personal data and to exercise your rights, please refer to the Privacy Policy. By clicking on Submit, I acknowledge that I have read and accepted the legal notice and the general terms of use of the site.

More key plays

Adapting service platforms (FSP) functionning to fit the client's new outsourcing strategy
Efficiently conducting a worldwide phase 2 clinical study with multiple partners
Achieving an end-to-end audit approval from Health Canada
Facilitate data mapping to SDTM by leveraging standardisation and A.I.
Speed up the development of clinical study documents
Transforming pediatric care through digital enablement
Medical device approved for Hearing Loss
Piloting through a pivotal study in cataract eye surgery helping patients recover their vision
Managing efficiently a large cohort RWE study, thanks to dedicated apparatus
Logo - Kls
Headquarters

155 rue Anatole France 92593 Levallois-Perret

Phone:+33 (0)1 41 34 10 00

Fax:+33 (0)1 41 34 10 10

LinkedInKlsInstagram
PlaybookServicesInsightsTechnologyCareersAbout us
Company purposeLife science innovationCommitted KeyrusRegulatory complianceInvestorsManagement teamKeyrus GroupLocations
Legal notice & Terms of use
Privacy policy
Data protection